Donald J. Kellerman, VP, Clinical Development & Med Affairs at Zosano Pharma Corp (ZSAN), sold 4,006 shares at $0.21 ($841) on 2022-03-31, disclosed to the SEC on 2022-04-01.
Open-market sale of $841 ZSAN by VP, Clinical Development & Med Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MAPP | SELL | 2013-02-04 | $35K | — | Filing → |